Desmet VJ. Vanishing bile duct syndrome in drug-induced liver disease. J Hepatol. 1997;26(Suppl 1):31–5.

Article  CAS  PubMed  Google Scholar 

Reau NS, Jensen DM. Vanishing bile duct syndrome. Clin Liver Dis. 2008;12:203–17.

Article  PubMed  Google Scholar 

Ahmad J, Barnhart HX, Bonacini M, et al. Value of liver biopsy in the diagnosis of drug-induced liver injury. J Hepatol. 2022;76:1070–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver Biopsy Hepatol. 2009;49:1017–44.

Google Scholar 

Geubel AP, Sempoux CL. Drug and toxin-induced bile duct disorders. J Gastroenterol Hepatol. 2000;15:1232–8.

CAS  PubMed  Google Scholar 

Bessone F, Hernandez N, Tanno M, Roma MG. Drug-induced vanishing bile duct syndrome: from pathogenesis to diagnosis and therapeutics. Semin Liver Dis. 2021;41:331–48.

Article  PubMed  Google Scholar 

Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology. 2011;53:1377–87.

Article  CAS  PubMed  Google Scholar 

Moradpour D, Altorfer J, Flury R, et al. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology. 1994;20:1437–41.

Article  CAS  PubMed  Google Scholar 

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012

Bonkovsky HL, Kleiner DE, Gu J, et al. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements. Hepatology. 2017;65:1267–77.

Article  CAS  PubMed  Google Scholar 

Schwarze C, Schmitz V, Fischer HP, Sauerbruch T, Spengler U. Vanishing bile duct syndrome associated with elevated pancreatic enzymes after short-term administration of amoxicillin. Eur J Gastroenterol Hepatol. 2002;14:1275–7.

Article  PubMed  Google Scholar 

Kim JS, Jang YR, Lee JW, et al. A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage. Korean J Hepatol. 2011;17:229–32.

Article  PubMed  PubMed Central  Google Scholar 

Li L, Zheng S, Chen Y. Stevens–Johnson syndrome and acute vanishing bile duct syndrome after the use of amoxicillin and naproxen in a child. J Int Med Res. 2019;47:4537–43.

Article  PubMed  PubMed Central  Google Scholar 

Smith LA, Ignacio JR, Winesett MP, et al. Vanishing bile duct syndrome: amoxicillin–clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid. J Pediatr Gastroenterol Nutr. 2005;41:469–73.

Article  CAS  PubMed  Google Scholar 

Li H, Li X, Liao XX, et al. Drug associated vanishing bile duct syndrome combined with hemophagocytic lymphohistiocytosis. World J Gastrointest Endosc. 2012;4:376–8.

Article  PubMed  PubMed Central  Google Scholar 

Hashim A, Barnabas A, Miquel R, Agarwal K. Successful liver transplantation for drug-induced vanishing bile duct syndrome. BMJ Case Rep. 2020;13:e233052.

Article  PubMed  PubMed Central  Google Scholar 

Faragalla K, Lau H, Wang HL, Liu J. Cloxacillin-induced acute vanishing bile duct syndrome: a case study and literature review. Br J Clin Pharmacol. 2022;88:4633–8.

Article  PubMed  Google Scholar 

Tajiri H, Etani Y, Mushiake S, Ozono K, Nakayama M. A favorable response to steroid therapy in a child with drug-associated acute vanishing bile duct syndrome and skin disorder. J Paediatr Child Health. 2008;44:234–6.

Article  PubMed  Google Scholar 

Zhao Z, Bao L, Yu X, et al. Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: a case report. Medicine (Baltimore). 2017;96:e8009.

Article  PubMed  Google Scholar 

Momen S, Dangiosse C, Wedgeworth E, Walsh S, Creamer D. A case of toxic epidermal necrolysis and vanishing bile duct syndrome, requiring liver transplantation. J Eur Acad Dermatol Venereol. 2017;31:e450–2.

Article  CAS  PubMed  Google Scholar 

Okan G, Yaylaci S, Peker O, Kaymakoglu S, Saruc M. Vanishing bile duct and Stevens–Johnson syndrome associated with ciprofloxacin treated with tacrolimus. World J Gastroenterol. 2008;14:4697–700.

Article  PubMed  PubMed Central  Google Scholar 

Robinson W, Habr F, Manlolo J, Bhattacharya B. Moxifloxacin associated vanishing bile duct syndrome. J Clin Gastroenterol. 2010;44:72–3.

Article  PubMed  Google Scholar 

Bataille L, Rahier J, Geubel A. Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn’s disease. J Hepatol. 2002;37:696–9.

Article  PubMed  Google Scholar 

Levine C, Trivedi A, Thung SN, Perumalswami PV. Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review. Semin Liver Dis. 2014;34:246–51.

Article  CAS  PubMed  Google Scholar 

Karnsakul W, Arkachaisri T, Atisook K, Wisuthsarewong W, Sattawatthamrong Y, Aanpreung P. Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms. Ann Hepatol. 2006;5:116–9.

Article  PubMed  Google Scholar 

Juricic D, Hrstic I, Radic D, et al. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man. Basic Clin Pharmacol Toxicol. 2010;106:62–5.

Article  PubMed  Google Scholar 

Silberstein SD. Migraine preventive treatment. Handb Clin Neurol. 2010;97:337–54.

Article  PubMed  Google Scholar 

Zubarev A, Haji K, Li M, Tiruvoipati R, Botha J. Meropenem-induced vanishing bile duct syndrome: a case report. J Int Med Res. 2020;48:1220737394.

Article  Google Scholar 

Cho HJ, Jwa HJ, Kim KS, Gang DY, Kim JY. Urosodeoxycholic acid therapy in a child with trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome. Pediatr Gastroenterol Hepatol Nutr. 2013;16:273–8.

Article  PubMed  PubMed Central  Google Scholar 

Kathi PR, Tama M, Ehrinpreis M, et al. Vanishing bile duct syndrome arising in a patient with HIV infection sequentially treated with trimethoprim/sulfamethoxazole and dapsone. Clin J Gastroenterol. 2020;13:276–80.

Article  PubMed  Google Scholar 

Lu MQ, Gong JY, Li CY, et al. A case of drug-associated vanishing bile duct syndrome. Chin J Pediatr. 2020;58(5):430–1 (in Chinese).

CAS  Google Scholar 

Li J, Zhao LL, Ye LH, et al. Two cases of drug⁃induced vanishing bile duct syndrome. Anhui Med Pharm J. 2019;23(5):1051–3 (in Chinese).

Google Scholar 

Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148:1340–52.

Article  PubMed  Google Scholar 

Wasuwanich P, Choudry H, So JM, Lowry S, Karnsakul W. Vanishing bile duct syndrome after drug-induced liver injury. Clin Res Hepatol Gastroenterol. 2022;46:102015.

Article  PubMed  Google Scholar 

Lakehal F, Dansette PM, Becquemont L, et al. Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes. Chem Res Toxicol. 2001;14:694–701.

Article  CAS  PubMed  Google Scholar 

Carey MA, van Pelt FN. Immunochemical detection of flucloxacillin adduct formation in livers of treated rats. Toxicology. 2005;216:41–8.

Article